Status:
ENROLLING_BY_INVITATION
Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes
Lead Sponsor:
Lawndale Christian Health Center
Collaborating Sponsors:
Northwestern University Feinberg School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patient populations at community health centers, specifically Black or African American and Hispanic or Latino populations with Type 2 diabetes, experience significant health disparities. In particula...
Detailed Description
This will be conducted at a Lawndale Christian Health Center, a community health center in the West Side of Chicago that serves a largely Black or African American and Hispanic or Latino population. T...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Have an assigned primary care provider
- Diagnosis of Type 2 diabetes
- Medication use is insulin
- HbA1c of 8.0% or higher
Exclusion
- Diagnosis of chronic kidney disease at Stage 4 or higher
- Diagnosis of pregnancy
- Diagnosis of behavioral health conditions including serious mental illness or severe depression in the past 6 months.
- All participants must have a smartphone that is able to access internet services.
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06517576
Start Date
December 1 2024
End Date
September 30 2025
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lawndale Christian Health Center
Chicago, Illinois, United States, 60623